Literature DB >> 918117

Spontaneous regression of breast cancer.

E F Lewison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 918117

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  5 in total

Review 1.  Disulfiram: a novel repurposed drug for cancer therapy.

Authors:  Chen Lu; Xinyan Li; Yongya Ren; Xiao Zhang
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-10       Impact factor: 3.333

2.  Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies.

Authors:  Ling Wang; Yang Yu; Cong Zhou; Run Wan; Yumin Li
Journal:  Syst Rev       Date:  2022-06-02

3.  Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells.

Authors:  P Liu; I S Kumar; S Brown; V Kannappan; P E Tawari; J Z Tang; W Jiang; A L Armesilla; J L Darling; W Wang
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640

4.  Comment on 'cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells'.

Authors:  B Cvek
Journal:  Br J Cancer       Date:  2013-01-22       Impact factor: 7.640

Review 5.  A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.

Authors:  Richard E Kast; John A Boockvar; Ansgar Brüning; Francesco Cappello; Wen-Wei Chang; Boris Cvek; Q Ping Dou; Alfonso Duenas-Gonzalez; Thomas Efferth; Daniele Focosi; Seyed H Ghaffari; Georg Karpel-Massler; Kirsi Ketola; Alireza Khoshnevisan; Daniel Keizman; Nicolas Magné; Christine Marosi; Kerrie McDonald; Miguel Muñoz; Ameya Paranjpe; Mohammad H Pourgholami; Iacopo Sardi; Avishay Sella; Kalkunte S Srivenugopal; Marco Tuccori; Weiguang Wang; Christian R Wirtz; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2013-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.